Show simple item record

dc.contributor.authorRasaeifar, Bahareh
dc.contributor.authorGómez Gutiérrez, Patricia
dc.contributor.authorPérez González, Juan Jesús
dc.contributor.otherUniversitat Politècnica de Catalunya. Doctorat en Tecnologia Agroalimentària i Biotecnologia
dc.contributor.otherUniversitat Politècnica de Catalunya. Doctorat en Polímers i Biopolímers
dc.contributor.otherUniversitat Politècnica de Catalunya. Departament d'Enginyeria Química
dc.date.accessioned2021-03-18T14:03:17Z
dc.date.available2021-03-18T14:03:17Z
dc.date.issued2020-08-17
dc.identifier.citationRasaeifar, B.; Gomez, P.; Perez, J. New insights into the stereochemical requirements of the bombesin BB1 receptor antagonists binding. "Pharmaceuticals", 17 Agost 2020, vol. 13, núm. 8, p. 197:1-197:16.
dc.identifier.issn1424-8247
dc.identifier.urihttp://hdl.handle.net/2117/342002
dc.description.abstractMembers of the family of bombesinlike peptides exert a wide range of biological activities both at the central nervous system and in peripheral tissues through at least three G-Protein Coupled Receptors: BB1, BB2 and BB3. Despite the number of peptide ligands already described, only a few small molecule binders have been disclosed so far, hampering a deeper understanding of their pharmacology. In order to have a deeper understanding of the stereochemical features characterizing binding to the BB1 receptor, we performed the molecular modeling study consisting of the construction of a 3D model of the receptor by homology modeling followed by a docking study of the peptoids PD168368 and PD176252 onto it. Analysis of the complexes permitted us to propose prospective bound conformations of the compounds, consistent with the experimental information available. Subsequently, we defined a pharmacophore describing minimal stereochemical requirements for binding to the BB1 receptor that was used in silico screening. This exercise yielded a set of small molecules that were purchased and tested, showing affinity to the BB1 but not to the BB2 receptor. These molecules exhibit scaffolds of diverse chemical families that can be used as a starting point for the development of novel BB1 antagonists.
dc.language.isoeng
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Spain
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.subjectÀrees temàtiques de la UPC::Enginyeria química::Biotecnologia
dc.subject.otherBombesin receptors
dc.subject.otherNeuromedin B antagonism
dc.subject.otherG-protein coupled receptors homology modeling
dc.subject.otherNon-peptide neuromedin B antagonists
dc.titleNew insights into the stereochemical requirements of the bombesin BB1 receptor antagonists binding
dc.typeArticle
dc.subject.lemacFarmacologia
dc.contributor.groupUniversitat Politècnica de Catalunya. GBMI - Grup de Biotecnologia Molecular i Industrial
dc.identifier.doi10.3390/ph13080197
dc.description.peerreviewedPeer Reviewed
dc.relation.publisherversionhttps://www.mdpi.com/1424-8247/13/8/197
dc.rights.accessOpen Access
local.identifier.drac29884742
dc.description.versionPostprint (published version)
local.citation.authorRasaeifar, B.; Gomez, P.; Perez, J.
local.citation.publicationNamePharmaceuticals
local.citation.volume13
local.citation.number8
local.citation.startingPage197:1
local.citation.endingPage197:16


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Spain
Except where otherwise noted, content on this work is licensed under a Creative Commons license : Attribution-NonCommercial-NoDerivs 3.0 Spain